Define Ventures’ new report provides a clear framework for how enterprise healthcare, particularly Big Pharma, is transitioning from AI exploration to execution. It focuses on core categories, ...

Amber Nigam is CEO and cofounder of basys.ai, a Harvard-based company streamlining prior authorization for health plans with generative AI. The pharmaceutical industry is at a significant crossroads, ...

AI has infiltrated seemingly every facet of business over the last year. The pharmaceutical industry is no different, and this technology’s rapid evolution can change drug development forever. However ...

Artificial intelligence (AI) has the potential to reshape the pharmaceutical industry, potentially cutting drug development time by up to 70% and reducing the number of clinical trial phases, ...

"The pharmaceutical industry is embracing generative AI for several key reasons. First, the industry deals with enormous volumes of information - scientific papers, clinical trial data, regulatory ...

Discover the latest pharma quality and manufacturing trends. Digital transformation in pharma is a key move to remain viable in a marketplace that is demanding more personalisation, more quickly than ...

What is Pharma 4.0? The term Industry 4.0 refers to the fourth industrial revolution, associated with the application of advanced technologies that have dramatically changed the landscape of ...

Microbial testing, analysis and environmental monitoring is fundamental to safe pharmaceutical manufacturing. Regulatory agencies require that the many components of the system implemented, from ...

Pharmaceutical manufacturing encompasses all processes involved in the manufacturing and production of biological and medical products, botanical drugs, and herbs, as well as other pharmaceutical ...